Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2020.2.51

Katina M.A., Lesnichaya O.V.
Large plaque parapsoriasis: clinicohistological parallels
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus

Vestnik VGMU. 2020;19(2):51-62.

Abstract.
Large plaque parapsorisis (LPP) is of great importance in the practice of dermatologists due to the difficulties of managing such patients. Problems are caused by nonspecific clinical, histological and immunohistochemical data in LPP and early patch stage of mycosis fungoides (MF).
Objectives. To assess the clinical and histological features of LPP and MF cases: to identify clinical and pathomorphological signs that require more intensive monitoring of patients with the diagnosis of LPP for early detection of MF, to develop an algorithm for examining patients with LPP for the improvement of the effectiveness of early-stage diagnosis of MF.
Material and methods. 15 inpatients with large plaque parapsoriasis and retrospectively 3 patients with advanced stages of MF, initially diagnosed as LPP were studied.
Results. Alarming clinical signs in relation to MF were detected in 14 (94%) patients, of which the most frequent were the following: localization of rashes in non-sunexposed areas (80%), different shape and size of rashes (73%), the appearance of new patches during the last 3-6 months (94%), the appearance of patches again after the discontinuation of topical steroid creams (74%), chaotic location of the rash (67%). There were no specific pathohistological findings of MF among the examined patients. However, the following signs identified in 5 (33%) patients can serve as alarming ones in relation to MF: focal (cell cluster arrangement) exocytosis of lymphocytes like microabscesses Pautrie with weakly expressed spongiosis, infiltration around the sebaceous glands, the presence of eosinophils and plasma cells, vacuole interface dermatitis, papillary dermis fibrosis. In this group of patients, the dynamic follow-up by a dermatologist is required with compulsory repeated biopsies after 6 months.
Conclusions. Based on the obtained data, including a retrospective analysis of clinical cases with late stages of MF, we propose an algorithm for the management of patients with large plaque parapsoriasis by dermatologists and dermatopathologists.
Key words: large plaque parapsoriasis, mycosis fungoides, pathohistology, clinical signs, immunohistochemistry, retrospective analysis.

References

1. Sehgal VN, Srivastava G, Aggarwal AK. Parapsoriasis: a complex issue. Skinmed. 2007 Nov-Dec;6(6):280-6. doi:10.1111/j.1540-9740.2007.06490.x
2. Baderca F, Chiticariu E, Baudis M, Solovan C. Biopsying parapsoriasis: quo vadis? Are morphological stains enough or are ancillary tests needed? Rom J Morphol Embryol. 2014;55(3 Suppl):1085-92.
3. Simon M, Flaig MJ, Kind P, Sander CA, Kaudewitz P. Large plaque parapsoriasis: clinical and genotypic correlations. J Cutan Pathol. 2000 Feb;27(2):57-60. doi:10.1034/j.1600-0560.2000.027002057.x
4. Kreuter A, Bischoff S, Skrygan M, Wieland U, Brockmeyer NH, Stücker M, et al. High Association of Human Herpesvirus 8 in Large-Plaque Parapsoriasis and Mycosis Fungoides. Arch Dermatol. 2008 Aug;144(8):1011-6. doi: http://dx.doi.org/10.1001/archderm.144.8.1011
5. Kelati A, Gallouj S, Tahiri L, Harmouche T, Mernissi FZ. Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis. Int J Womens Dermatol. 2017 Jan;3(2):100-106. doi:10.1016/j.ijwd.2016.11.006.
6. Harvey NT. Spagnolo DV, Wood BA. ‘Could it be mycosis fungoides?’: an approach to diagnosing patch stage mycosis fungoides. J Hematopathol. 2015;8:209-23.
7. Pujol RM, Gallardo F, Llistosella E, Blanco A, Bernadó L, Bordes R, et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S168-71. doi:10.1067/mjd.2002.107231.
8. Wilcox RA. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011 Nov;86(11):928-48. doi: http://dx.doi.org/10.1002/ajh.22139
9. Harvey NT, Spagnolo DV, Wood BA. Could it be mycosis fungoides?’: an approach to diagnosing patch stage mycosis fungoides. J Hematopathol. 2015;8:209-23. doi: http://dx.doi.org/10.1007/s12308-015-0247-2
10. Everett MA. Early diagnosis of Mycosis fungoides: vacuolar interface dermatitis / M. A. Everett. J Cutan Pathol. 1985 Jun-Aug;12(3-4):271-8. doi:10.1111/j.1600-0560.1985.tb01629.x.
11. Jaque A, Mereniuk A, Sade S, Lansang P, Imrie K, Shear NH, et al. Eosinophils in the skin-a red herring masking lymphoma: a case series. SAGE Open Med Case Rep. 2018 May;6:2050313X18773127. doi: http://dx.doi.org/10.1177/2050313X18773127
12. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005 Dec;53(6):1053-63. doi:10.1016/j.jaad.2005.08.057
13. Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of Histologic Criteria for Diagnosing Early Mycosis Fungoides. Am J Surg Pathol. 2000 Jan;24(1):40-50. doi:10.1097/00000478-200001000-00005
14. Wilcox RA. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management / R. A. Wilcox. Am J Hematol. 2011 Nov;86(11):928-48. doi: http://dx.doi.org/10.1002/ajh.22139.doi:10.1002/ajh.22139
15. Calonje JE, Brenn T, Lazar A, McKee P. McKee's Pathology of the Skin. 4th ed. Saunders; 2012.
16. Vorontsova AA, Karamova AE, Znamenskaya LF. Current understanding of the pathogenesis of fungal mycosis. Onkogematologiia. 2018;13(3):39-46. (In Russ.)
17. Fujii K, Kanekura T. Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma. Front Med (Lausanne). 2019 Aug;6:181. doi:10.3389/fmed.2019.00181
18. Sufficool KE, Lockwood CM, Abel HJ, Hagemann IS, Schumacher JA, Kelley TW, et al. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. J Am Acad Dermatol. 2015 Aug;73(2):228-36. doi:10.1016/j.jaad.2015.04.030
19. McGirt LY, Degesys CA, Johnson VE, Zic JA, Zwerner JP, Eischen CM. TOX expression and role in CTCL. J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1497-502. doi:10.1111/jdv.13651

Information about authors:
Katina M.A. – Candidate of Medical Sciences, associate professor of the Chair of Dermatovenerology, Vitebsk State Order of Peoples’ Friendship Medical University;
Lesnichaya O.V. – Candidate of Medical Sciences, associate professor of the Chair of Pathologic Anatomy with the course of Forensic Medicine, Vitebsk State Order of Peoples’ Friendship Medical University.

Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Dermatovenerology. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Mariya A. Katina.

Поиск по сайту